Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion
Min-zheng Zhu,Hao-ming Xu,Yu-jie Liang,Jing Xu,Ning-ning Yue,Yuan Zhang,Cheng-mei Tian,Jun Yao,Li-sheng Wang,Yu-qiang Nie,De-feng Li
DOI: https://doi.org/10.1186/s12951-023-02065-0
IF: 10.2
2023-09-02
Journal of Nanobiotechnology
Abstract:Plant-derived exosome-like nanoparticles (PDENs) have been paid great attention in the treatment of ulcerative colitis (UC). As a proof of concept, we isolated and identified Portulaca oleracea L-derived exosome-like nanoparticles (PELNs) from edible Portulaca oleracea L, which exhibited desirable nano-size (~ 160 nm) and a negative zeta potential value (-31.4 mV). Oral administration of PELNs effectively suppressed the expressions of pro-inflammatory cytokines (TNF-α, IL-6, IL-12, and IL-1β) and myeloperoxidase (MPO), increased levels of the anti-inflammatory cytokine (IL-10), and alleviated acute colitis in dextran sulfate sodium (DSS)-induced C57 mice and IL-10 −/− mice. Notably, PELNs exhibited excellent stability and safety within the gastrointestinal tract and displayed specific targeting to inflamed sites in the colons of mice. Mechanistically, oral administration of PELNs played a crucial role in maintaining the diversity and balance of gut microbiota. Furthermore, PELNs treatment enhanced Lactobacillus reuteri growth and elevated indole derivative levels, which might activate the aryl-hydrocarbon receptor (AhR) in conventional CD4 + T cells. This activation downregulated Zbtb7b expression, leading to the reprogramming of conventional CD4 + T cells into double-positive CD4 + CD8 + T cells (DP CD4 + CD8 + T cells). In conclusion, our findings highlighted the potential of orally administered PELNs as a novel, natural, and colon-targeted agent, offering a promising therapeutic approach for managing UC.
biotechnology & applied microbiology,nanoscience & nanotechnology